| Engineer | Form: (02)
400731442
12/10/2014 | (1) Operator shall comply with the most current revision of the Northwest Notification Policy. See attached notice.
(2) Operator shall comply with the most current revision of the Garfield County Rulison Field Notice to Operators, with the following exception: All field notice requirements specified in that Notice to Operators are superseded by the requirements of the most current revision of the Northwest Colorado Notification Policy (see Condition of Approval #1). See attached notice.
(3) Operator shall provide cement coverage from the production casing shoe to a minimum of 200' above all Mesa Verde Group (and Ohio Creek Formation, if present) oil, gas, and water-bearing sandstone and coalbed formations. Verify production casing cement coverage with a cement bond log.
(4) Approval of this form does not authorize injection. Authorization to inject requires approval of Form 31 and Form 33.
(5) Before stimulating the objective injection formation(s), collect water sample(s) and analyze for Total Dissolved Solids.
(6) Prior approval of Form 4 is required for step rate and injectivity tests.
|
| UIC | Form: (02)
400731442
12/31/2014 | 1. For all new drill Underground Injection Control wells a suite of open-hole Resistivity/Gamma Ray and Density/Neutron logs is required from Surface Casing shoe to TD. A PDF, TIFF, or PDS visual image and a LAS or DILS file version of each log is required.
2. For all new and converted Underground Injection Control wells a Cement Bond Log (CBL) is a required on the cased portions of the hole from the bottom of the casing to the top of the next shallower casing string for all casing strings other than the Surface Casing. Only a PDF, TIFF, or PDS visual image is required.
3. Operator must provide all tops of formations encountered from surface to TD on the Form 5 when submitted.
|
| UIC | Form: (04)
400866136
07/10/2015 | Water sample must be collected prior to injection related to the DFIT test. |
| UIC | Form: (04)
401835015
02/22/2019 | Provide summary of treatment procedure and documentation with results, if any, by March 31, 2019. |